November 1, 2023
Retinoblastoma Articles
October 1, 2023
SUBSPECIALTY NEWS: Biosimilar FDA application hits roadblock, Apellis provides guidance on Syfovre use, and more.
By Rochelle Nataloni, contributing writer
July 1, 2023
SUBSPECIALTY NEWS: Mydriasis spray approved, laser and imaging devices cleared, new AI technology, and more.
By Rochelle Nataloni, contributing writer
July 1, 2023
Clinical Trial Update July/August 2023
June 1, 2023
A Simple Guide for Treating Retinoblastoma
By Vishal R. Raval, MD, Stacey G. Zahler, DO, MS, Arun D. Singh, MD
June 1, 2023
UPFRONT: Failure Is Not Trying
By Peter K. Kaiser, MD
Advertisement
Recommendations
Advertisement